Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.305 per share of common stock. The dividend will be payable on October 2, 2025, to stockholders of record at the close of business on September 17, 2025.
This represents a 1.7% increase compared to the dividend declared in the same quarter of the previous year. The company specializes in healthcare products for women and their babies, manufacturing specialty medical devices used by clinicians globally.
Positive
- Dividend increased by 1.7% year-over-year
- Consistent dividend payment demonstrates financial stability
- Global market presence in over 100 countries
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, UTMD declined 2.34%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire